News and Announcements
Leading health-tech company, Shivom raise $35 million during ICO
- Published December 18, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- The health-tech company raised $35 million during ICO
- MOU agreement signed with the State of Andhra Pradesh Government
- SignularityNet Partnership
- Genetic Technologies Limited Partnership
- eMQT Partnership
- Diabetes Programme
- Alpha Platform Release
Shivom is a leading health-tech company Shivom is a leading health-tech company focused on developing the world’s largest DNA data and healthcare services platform powered by blockchain technology.
This past year has been eventful for the company adding multiple partnerships from SingularityNet to Genetic Technologies Limited.
The company also launched their Diabetes study in September with the goal of finding unique genetic markers specific to Indian subpopulations that may help explain why the country has one of the highest rising prevalence’s of Type 2 Diabetes in the world.
Shivom opened up the end of the last quarter with the launch of their alpha release.
The release allows individuals to upload and store their DNA data securely, more importantly,
they ‘own’ their data so that they can choose to monetise it in the future, getting their fair
share of the $70bn pharmaceutical companies are paying annually for research and
development trials.
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
